“Determining the directions for developing a methodology for comprehensive assessment of ESG activity in China’s biopharmaceutical territorial-sectoral complexes” (2025) Modern Economics: Problems and Solutions, 12, pp. 61–74. doi:10.17308/meps/2078-9017/2025/12/61-74.